Dataset ID | Technology | Samples |
---|---|---|
EGAD00010001542 | Illumina DASL Assay | 42 |
Dataset Description
Data Use Conditions
NRES
See further information on Data Use Conditions
Label | Code | Version | Modifier |
---|---|---|---|
no restriction | DUO:0000004 | 2019-01-07 |
Dataset ID | Technology | Samples |
---|---|---|
EGAD00010001542 | Illumina DASL Assay | 42 |
NRES
See further information on Data Use Conditions
Label | Code | Version | Modifier |
---|---|---|---|
no restriction | DUO:0000004 | 2019-01-07 |
For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:
BC Cancer, part of the Provincial Health Services Authority, Technology Development Office, Data Access Committee (PHSA TDO DAC)
Contact person: Sarah Jane Lee
Email: tdoadmin [at] phsa [dot] ca
More details: EGAC00000000011
Studies are experimental investigations of a particular phenomenon. e.g. case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients. Click on one of the Study IDs below to find out more.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001002796 | Somatic IL4R Hotspot Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT activation | Other |